Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Cash from Investing Activities (2018 - 2025)

Historic Cash from Investing Activities for Viemed Healthcare (VMD) over the last 8 years, with Q3 2025 value amounting to -$32.3 million.

  • Viemed Healthcare's Cash from Investing Activities fell 54996.98% to -$32.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$51.8 million, marking a year-over-year decrease of 7849.21%. This contributed to the annual value of -$30.7 million for FY2024, which is 4109.15% up from last year.
  • As of Q3 2025, Viemed Healthcare's Cash from Investing Activities stood at -$32.3 million, which was down 54996.98% from -$1.7 million recorded in Q2 2025.
  • Viemed Healthcare's 5-year Cash from Investing Activities high stood at -$1.7 million for Q1 2021, and its period low was -$32.3 million during Q3 2025.
  • In the last 5 years, Viemed Healthcare's Cash from Investing Activities had a median value of -$6.7 million in 2022 and averaged -$8.9 million.
  • Over the last 5 years, Viemed Healthcare's Cash from Investing Activities had its largest YoY gain of 8453.48% in 2025, and its largest YoY loss of 54996.98% in 2025.
  • Over the past 5 years, Viemed Healthcare's Cash from Investing Activities (Quarter) stood at -$6.6 million in 2021, then fell by 12.42% to -$7.4 million in 2022, then dropped by 1.56% to -$7.5 million in 2023, then fell by 22.75% to -$9.2 million in 2024, then tumbled by 251.13% to -$32.3 million in 2025.
  • Its Cash from Investing Activities stands at -$32.3 million for Q3 2025, versus -$1.7 million for Q2 2025 and -$8.5 million for Q1 2025.